The next focusIR Investor Webinar takes places on 14th May with guest speakers from Blue Whale Growth Fund, Taseko Mines, Kavango Resources and CQS Natural Resources fund. Please register here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Agreed scinv, I see through your jealousy of RM
You know what is ridiculous? The same people that post these nonsense comments and then complain that people make childish comments and ruin the climate and the board. You are doing more damage than you think, anyone remotely serious and over the age of 12 can see right through it. It is YOU who is pushing away any new investors that might visit this board.
Straw man response
Ray,
To be fair, most TV sets have zero athletic ability. Not the reason to shout at them, of course. :-)
I don't think Scinv is evil enough to abuse a TV set; perhaps he kicks a sofa or smashes an ironing board once in a while, but a TV set? Nah, can't see that happening. Au contraire, he probably loves TV and watches it 24/7.
Novel?
SNG did not discover the value of interferon and they did not discover the value of formulsting them in inhalable format either. Sure they have their own formulation and it has to to through the trials to get approved as a drug, but neither the active ingredient nor the concept are novel, let's not get carried away.
ivSkin, stop being so silly, you know full well the price of novel drugs arnt set by the cost of one active ingredient, the bulk of the cost will be in logistics, fill & finish and distribution, but I'm sure you're well aware of that.
Of course not scinv, otherwise I wouldn't be invested :)
I'm not the CEO am I?
Lol, are you 12 or something?
He reminds me of the armchair football fan screeming at the TV with zero athletic ability
Ray - of course he could....as could all of us....’armchair’ CEOs - I’m a great manager too on FIFA!
Do you think you could do better scinv?
Sorry Ghia but no.
"the fact SNG will be efficiently mass produced"
Fact?
"The fact is the cost to produce SNG001 will be on par with other medicines."
Cause they are all the same, right?
For example monoclonal ab doses are between 300 and 800mg or more and they are also produced in mamalian cells.
25 ug of ifnb beta is between 1000 and 2500 times less than that. The limiting factor is how much protein the cells produce in a given amount of time, that is measured in units of weight not in how many protein molecules (ifn is a lot smaller than an antibody). This is good, it means manufacturing is a lot less expsensive than the monoclonal antibody above.
"He has been very non comital ref pricing thus far even suggesting the cost will vary depending on target market."
This is precious. He has been non commital after touting about pricing similar to remdesivir and £2.5K or £3K per treatment for months. Perhaps he learned something now, if that was soon enough, we'll find out.
Apart from the fact SNG will be efficiently mass produced.
The pricing conversation is pointless to have right now.
The fact is the cost to produce SNG001 will be on par with other medicines.
What SNG end up charging will be dependant on the strength of the data and the value proposition it presents to the markets.
There will be a sweet spot and I trust RM will hit that.
He has been very non comital ref pricing thus far even suggesting the cost will vary depending on target market.
Simply ruling it out based on being too expensive is a bit naive.
Right, did all the car manufacturers call it a day when Henry Ford rocked up in some piece of **** car.
Go to bed and come back in May you gang of bores!!!